Yasuhiro Maejima Selected Research

Yasuhiro Maejima Research Topics

Disease

14	Heart Failure 03/2024 - 11/2008
9	Myocardial Infarction 01/2023 - 01/2007
9	Takayasu Arteritis (Arteritis, Takayasu's) 01/2021 - 08/2013
8	Cardiomegaly (Heart Hypertrophy) 01/2021 - 08/2006
7	Myocarditis (Carditis) 01/2023 - 04/2005
7	Fibrosis (Cirrhosis) 01/2021 - 01/2007
5	Infarction (Infarctions) 03/2012 - 07/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 08/2006
4	Ischemia 01/2019 - 08/2003
4	Hypertrophy 05/2018 - 08/2006
4	Ventricular Remodeling 06/2011 - 01/2007
3	Infections 12/2023 - 08/2003
3	COVID-19 01/2023 - 01/2021
3	Inflammation (Inflammations) 01/2021 - 06/2006
3	Heart Diseases (Heart Disease) 01/2020 - 06/2006
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2018 - 03/2011
3	Myocardial Ischemia (Ischemic Heart Diseases) 03/2012 - 02/2007
3	Hyperplasia 05/2010 - 06/2006
2	Periodontitis 01/2023 - 01/2022
2	Heart Rupture 01/2023 - 10/2016
2	Atherosclerosis 01/2022 - 12/2021
2	Cardiomyopathies (Cardiomyopathy) 01/2021 - 10/2018
2	Hemorrhage 01/2021 - 06/2017
2	Thrombosis (Thrombus) 01/2021 - 06/2017
2	Hypertension (High Blood Pressure) 01/2017 - 10/2010
2	Arteriosclerosis 05/2010 - 09/2005
2	Reperfusion Injury 11/2008 - 07/2004
2	Vascular System Injuries 06/2008 - 12/2006
1	Carpal Tunnel Syndrome 03/2024
1	Amyloidosis 03/2024
1	Rotator Cuff Injuries 03/2024
1	Chagas Cardiomyopathy 12/2023
1	Cardiotoxicity 10/2023
1	Mesothelioma 06/2023
1	Stroke (Strokes) 01/2023
1	Vasculitis (Vasculitides) 01/2023
1	Aortic Rupture 01/2023
1	Unstable Angina 01/2023
1	Aortic Dissection 01/2023
1	Death (Near-Death Experience) 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Periodontal Diseases (Periodontal Disease) 01/2022
1	Atrial Fibrillation 01/2022

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2003
6	Beclin-1IBA 01/2022 - 12/2010
4	Angiotensin IIIBA 01/2021 - 08/2006
4	CytokinesIBA 09/2017 - 07/2004
4	NF-kappa B (NF-kB)IBA 07/2011 - 07/2004
4	PPAR gammaIBA 06/2011 - 06/2006
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2017
3	C-Reactive ProteinIBA 01/2023 - 01/2020
3	GlucocorticoidsIBA 01/2021 - 01/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2018 - 08/2006
2	Gingipain Cysteine EndopeptidasesIBA 01/2023 - 10/2016
2	InflammasomesIBA 01/2022 - 12/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 10/2018
2	tocilizumab (atlizumab)FDA Link 01/2021 - 01/2020
2	SteroidsIBA 01/2021 - 01/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 07/2019
2	Serine (L-Serine)FDA Link 01/2019 - 12/2008
2	Phosphotransferases (Kinase)IBA 01/2019 - 08/2003
2	HLA-B Antigens (HLA-B)IBA 12/2018 - 08/2013
2	SaltsIBA 05/2018 - 10/2010
2	Angiotensin Receptor AntagonistsIBA 05/2018 - 01/2011
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 05/2014 - 07/2011
2	Matrix Metalloproteinases (MMPs)IBA 06/2011 - 02/2007
2	Telmisartan (Micardis)FDA Link 06/2011 - 05/2010
2	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2011 - 01/2007
2	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2011 - 01/2007
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 06/2011 - 11/2010
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2011 - 07/2008
2	Sirtuin 1IBA 12/2010 - 11/2010
2	Phenobarbital (Luminal)FDA Link 05/2010 - 06/2006
2	Cyclin D1IBA 11/2008 - 08/2006
2	Pioglitazone (Actos)FDA Link 07/2008 - 06/2006
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2007 - 04/2005
2	N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA 01/2007 - 07/2004
2	Cardiac MyosinsIBA 06/2006 - 04/2005
1	Prealbumin (Transthyretin)IBA 03/2024
1	Amyloid (Amyloid Fibrils)IBA 03/2024
1	Glutathione (Reduced Glutathione)IBA 12/2023
1	NitrogenIBA 12/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023
1	RNA (Ribonucleic Acid)IBA 12/2023
1	AnthracyclinesIBA 10/2023
1	NivolumabIBA 06/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	Leucine (L-Leucine)FDA Link 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	insulin receptor-related receptor (IRR)IBA 01/2023
1	mRNA VaccinesIBA 01/2022
1	Eplerenone (Inspra)FDA LinkGeneric 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022

Therapy/Procedure

8	Therapeutics 06/2023 - 04/2005
3	Transplantation 05/2010 - 12/2006
3	Ligation 11/2008 - 01/2007
2	Secondary Prevention 01/2023 - 02/2019
2	Percutaneous Coronary Intervention 01/2022 - 02/2019
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2017
2	Stents 02/2019 - 06/2017